YI SUN医学院 | 浙江大学转化医学研究院基础医学· Cullin-RING ligase（CRL)泛素连接酶在肿瘤发生发展中的作用及机理· 蛋白质的 Neddylation 修饰与肿瘤的关系· 靶向Neddylation-CRL的小分子抗癌药物的研发个人简介:教育背景1986/02-1989/05  美国爱荷华大学，放射生物专业，博士1982/02-1985/12  浙江医科大学，生物化学专业，硕士1978/02-1982/12  江西医学院，医疗专业，本科研究工作经历2014/01-至今    浙江大学转化医学研究院院长，教授，博士生导师，            中组部“千人计划”特聘专家，美国科学促进会会士2008/09-2013/12  美国密西根大学放射肿瘤生物系终身教授2006/09-2008/08  美国密西根大学放射肿瘤生物系终身副教授2003/08-2006/08  美国密西根大学放射肿瘤生物系副教授2002/02-2003/07  辉瑞(Pfizer)癌症分子科学全球研究部门资深研究员1995/01-2002/01  帕克戴维斯(Parke-Davis)癌症研究所高级研究员1992/09-1994/12  美国国立癌症研究所(NCI)高级研究员1990/01-1992/07  美国国立癌症研究所(NCI)高级博士后研究领域与转化潜能:研究领域1.       Cullin-RING ligase（CRL）泛素连接酶在肿瘤发生发展中的作用及机理2.       蛋白质的Neddylation修饰与肿瘤的关系3.       靶向Neddylation-CRL的小分子抗癌药物的研发关键实验技术1.       条件性转基因小鼠动物模型构建及后续肿瘤形成的分析2.       检测蛋白泛素化和类泛素化的生化分析3.       细胞增殖、凋亡、自噬和衰老的细胞生物学检测技术4.       基因过表达及siRNA沉默的分子生物学技术5.       组织学，病理学常规技术手段6.       高通量药物筛选技术转化潜能1.       小分子泛素连接酶抑制剂的抗癌作用2.       小分子类泛素化酶抑制剂的抗癌作用3.       肿瘤的生物标志物的鉴定--用于早期诊断和预后分析研究与成果:近期主要论著（共200余篇）1.    Zhou W. XuJ.Tan M. Zhang J. Li H.Li H. Wei W.Sun Y.: UBE2M is a stress-inducible dual E2 for neddylation and ubiquitylation that promotes targeted degradation of UBE2F. Mol. Cell 2018 Jun 21;70(6):1008-1024.e6.2.    Zhao Y. Tan M. Liu X. Xiong X. Sun Y.: Inactivation of ribosomal protein S27-like confers radiosensitivity via the Mdm2-p53 and Mdm2-MRN-ATM axes. Cell Death Dis. 2018 Feb 2;9(2):145.3.    Zhou W. Xu J. Li H. Xu M. Chen Z.J. Wei W. Pan Z. and Sun Y.: Neddylation E2 UBE2F promotes the survival of lung cancer cells by activating CRL5 to degrade NOXA via the K11 linkage. Clinical Cancer Res. 2017 23:1104-1116.4.    Xu J. Zhou W. Yang F. Chen G. Li H. Zhao Y. Liu P. Li H. Tan M. Xiong X. and Sun Y.: The βTrCP-FBXW2-SKP2 axis regulates lung cancer cell growth with FBXW2 acting as a novel tumor suppressor. Nature Communs 2017 Jan 16;8:14002. doi: 10.1038/ncomms14002.5.    Zhou H. Lu J. Liu L. Bernard D. Yang C.-Y. Chinnaswamy K. Layton S. Jeanne Stuckey J. Yu Q. Zhou W. Pan Z. Sun Y. and Wang S.:  A potent small-molecule inhibitor of the DCN1-UBC12 interaction that selectively blocks cullin 3 neddylation.Nat Communs. 2017 Oct 27;8(1):1150. doi: 10.1038/s41467-017-01243-7.6.    Zhang Q. Karnak D. Tan M. Lawrence T.S. Morgan M.A. Sun Y.: FBXW7 facilitates nonhomologous end-joining via K63-linked polyubiquitylation of XRCC4. Mol. Cell 2016 61: 419-433..7.    Wu K. Chong R. A. Yu Q. Bai J. Spratt D. E.  Ching K. Lee C.  Miao H. Zheng N. Shaw G. S.  Sun Y. Felsenfeld D. P. Sanchez R. Zheng J.-N. and Pan. Z.-Q.: Suramin inhibits cullin-RING E3 ubiquitin ligases. Proc. Natl. Acad. Sci. USA. 2016 113 (14) E2011-E2018.8.    Zhou X. Tan M. Nyati M. Zhao Y. Wang G.X. and Sun Y.: Blockage of neddylation modification stimulates tumor sphere formation in vitro and stem cell differentiation and wound healing in vivo. Proc. Natl. Acad. Sci. USA.2016 May 24;113(21):E2935-2944. doi: 10.1073/pnas.1522367113.9.    Lan H. Tang Z. Jin H. and Sun Y.: Neddylation inhibitor MLN4924 suppresses growth and migration of human gastric cancer cells. Sci Rep. 2016 Apr 11; 6:24218. doi: 10.1038/ srep24218. PMID: 27063292.10. Kuang P. Tan M. Zhang Q. and Sun Y.: SAG/RBX2 E3 ligase complexes with UBCH10 and UBE2S E2s to ubiquitylate β-TrCP1 via K11-linkage for degradation.  Sci Rep 2016 6:37441. DOI: 10.1038/srep37441.11. Tan M. Xu J. Feng F. and Sun Y.: Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis. Mol. Cancer Mol Cancer. 2016 Dec 12;15(1):81.PMID:27955654.12. Xie C. M. Wei D. Zhao L. Marchetto S. Mei L. BorgJ.-P.and Sun Y.:Erbin is a novel substrate of Sag-βTrCP E3 ligase that regulates KrasG12D-induced skin tumorigenesis. J. Cell Biol 2015 209: 721-737.13. Xiong X.* Zhao Y.* Tang F. Thomas D. Wang X. Liu Y. Zheng P. and Sun Y.: Ribosomal protein S27-like is a physiological inhibitor of p53 that paradoxically suppresses tumorigenesis.eLife. Aug 21: e02236. doi: 10.7554/eLife.02236.14. Li H.* Tan M.* Jia L. Wei D. Zhao Y. Chen G. Xu J. Zhao L. Thomas D. Beer D.G. and Sun Y.: Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis. J. Clin. Invest. 2014 Feb 3;124(2):835-46. doi: 10.1172/JCI70297.15. Zhou W. Wei W. and Sun Y.: Genetically engineered mouse models for functional studies of SCF E3 ubiquitin ligases. Cell Res. 23: 599-619 2013.16. Wei D. Li H. Yu J. Sebolt J. T. Zhao L. Lawrence T. S. Smith P. G. Morgan M. A. and Sun Y.: Radiosensitization of human pancreatic cancer cells by MLN4924 an investigational NEDD8-activating enzyme inhibitor. Cancer Res. 2012 72: 282-293.17. Tan M*. Zhao Y*. Kim S. Liu M. Jia L. Saunders T. Zhu Y. and Sun Y.: SAG/RBX2/ROC2 E3 ubiquitin ligase is essential for vascular and neural development by targeting NF1 for degradation. Dev. Cell 21:1062-76 2011.18. Zhao Y. Xiong X. and Sun Y.: DEPTOR an mTOR inhibitor is a physiological substrate of SCFβTrCP E3 ubiquitin ligase and regulates survival and autophagy. Mol. Cell 44: 304-316 2011.教学与课程:承担《分子医学》课程的如下部分内容：肿瘤生物学肿瘤治疗蛋白泛素化降解与癌症荣誉与奖励:2000   Alice Hamilton Award for Scientific Excellence National Institute for Occupational Safety and Health (NIOSH) 01/1999-   湖南医科大学客座教授05/2001-   江西医学院/南昌大学客座教授12/2012-   上海交通大学客座教授2012-   美国科学促进会 (AAAS) 会士 （Fellow）2013-   中组部“千人计划”专家